SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-018413
Filing Date
2020-09-28
Accepted
2020-09-28 11:13:23
Documents
7
Period of Report
2020-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 34827
2 ex10-1.htm EX-10.1 20060
3 ex10-2.htm EX-10.2 21021
4 ex10-3.htm EX-10.3 21424
5 ex10-1_001.jpg GRAPHIC 3491
6 ex10-2_001.jpg GRAPHIC 3417
7 ex10-3_001.jpg GRAPHIC 3417
  Complete submission text file 0001493152-20-018413.txt   113322
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 201202761
SIC: 2835 In Vitro & In Vivo Diagnostic Substances